Firefly Neuroscience, Inc. AIFF
Computer Software: Prepackaged Software · data as of November 13, 2026
Firefly Neuroscience, Inc. (AIFF) is a technology company listed in the US with a market value of about $15M. In the twelve months to September 30, 2026 it had revenue of $2M and net income of -$8M, a net margin of -386.2%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -39% a year, a 5-year average ROIC of -122%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 96% below the current price.
About Firefly Neuroscience
Firefly Neuroscience is listed in the US and classified in computer software: prepackaged software. Revenue went from $6M in 2014 to $1M in 2025, a decline of about 13.7% a year. It was profitable in 2 of the last 10 years in our data. Its share count rose by 603% over three years (dilution for shareholders). It spends 130% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $108000 | $498000 | $12M | $15M | $14M | $10M | $9M | $11M | $7M |
| Net income | -$8M | -$20M | -$10M | -$3M | -$18M | -$1M | $413379 | -$717246 | -$51034 | $246462 | -$553681 |
| Free cash flow | — | — | — | -$2M | -$7M | -$804769 | $358718 | -$925514 | -$769273 | $835227 | -$269926 |
| EPS (diluted) | $-0.46 | $-1.97 | $-1.60 | $-0.81 | $-10.03 | $-0.92 | $0.31 | $-0.61 | $0.00 | $0.20 | $-0.51 |
| Net margin | -386.2% | -1741.0% | -9685.2% | -522.7% | -147.7% | -7.5% | 3.0% | -7.1% | -0.6% | 2.3% | -8.2% |
| ROIC | — | -91.6% | — | -267.5% | — | -7.4% | 19.5% | -43.8% | -2.6% | 9.9% | -27.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Firefly Neuroscience stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 96% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Firefly Neuroscience pay a dividend?
Not currently.
Is Firefly Neuroscience a good stock to buy?
We do not give buy or sell advice. Firefly Neuroscience scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.